## **Core Concept**
The management of acute migraine attacks focuses on relieving symptoms and improving quality of life. The treatment often involves **triptans**, which are selective serotonin receptor agonists. These drugs work by causing vasoconstriction of intracranial blood vessels and inhibiting pro-inflammatory neuropeptide release.

## **Why the Correct Answer is Right**
The correct answer, **Sumatriptan**, is a **5-HT1 receptor agonist**. It is effective in relieving headache and other symptoms of migraine, such as nausea and vomiting, by inducing vasoconstriction of intracranial blood vessels and modulating neurotransmitter release. Sumatriptan has a rapid onset of action and is available in various formulations, including oral, nasal spray, and injectable forms, making it versatile for acute migraine treatment.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because **Ergotamines**, although historically used for migraine, have a slower onset of action and more side effects compared to triptans. They are less specific in their mechanism and can cause more prolonged vasoconstriction.
- **Option B:** This option is incorrect as **Propranolol** is a beta-blocker used for **prophylactic treatment of migraine**, not for acute attacks. It helps reduce the frequency and severity of migraine episodes but does not abort an acute attack.
- **Option D:** This option is incorrect because **Acetaminophen (paracetamol)** can be used for mild to moderate pain and may help with migraine symptoms to some extent but is not as effective as triptans for acute migraine attacks, especially for moderate to severe migraine.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for acute migraine attacks, **triptans** are the first-line treatment due to their efficacy and rapid onset of action. However, their use should be limited to **2-3 times per week** to avoid medication overuse headache.

## **Correct Answer:** . Sumatriptan